文献速递创伤与烧伤重症综合管理与镇静镇痛

高再出血风险创伤性脑损伤患者化学性与机械性静脉血栓栓塞预防的探索性分析

An Exploratory Analysis of Chemical and Mechanical VTE Prophylaxis in Patients with High Rebleeding Risk Traumatic Brain Injury.
PubMed 文献 · Neurocrit Care · 2025-05-21
一句话结论高再出血风险创伤性脑损伤患者中,24小时内启动化学性静脉血栓栓塞预防与ICU停留和通气天数减少相关,且不增加死亡率。

本研究为回顾性队列研究,使用美国外科医师学会创伤质量项目2017至2022年数据,纳入接受化学或机械性静脉血栓栓塞预防、无缺失时间且按改良Berne Norwood标准分层为高再出血风险的成人钝性创伤性脑损伤患者,排除多发伤,共13016例。按静脉血栓栓塞预防时机分为12个暴露组,结局为ICU停留、通气天数和死亡率。结果显示,无论既往是否使用抗凝药或存在出血性疾病,24小时内启动化学性静脉血栓栓塞预防与ICU停留延长和通气天数减少的可能性降低相关;而在24小时以上至72小时内放置下腔静脉滤器与ICU和通气时间延长相关。结论认为,高再出血风险创伤性脑损伤患者24小时内启动化学性静脉血栓栓塞预防可显著减少ICU停留和通气天数而不增加死亡率,下腔静脉滤器与更长ICU停留和通气天数相关可能反映所治疗疾病的严重程度和潜在死亡风险。

要点

  • 高再出血风险创伤性脑损伤患者中,24小时内(≤24 h)启动化学性静脉血栓栓塞预防与ICU停留延长和通气天数减少的可能性降低相关, regardless of prior anticoagulation use or bleeding disorder。
  • 在>24小时至<72小时窗口内放置下腔静脉滤器与ICU停留和通气时间延长相关。
  • 24小时内启动化学性静脉血栓栓塞预防未增加死亡率。
  • 下腔静脉滤器与更长ICU停留和通气天数相关,可能反映所治疗疾病的严重程度和潜在死亡风险。

适用人群与场景

  • 成人钝性创伤性脑损伤患者,按改良Berne Norwood标准分层为高再出血风险,接受化学或机械性静脉血栓栓塞预防且无缺失时间,按既往抗凝或出血性疾病病史分层,排除多发伤。

诊断标准与关键阈值

  • 高再出血风险按改良Berne Norwood标准分层。

处置流程与药物剂量

  • 化学性静脉血栓栓塞预防在≤24小时内启动。
  • 下腔静脉滤器在>24小时至<72小时窗口内放置。

研究设计与关键结果

  • 回顾性队列研究,使用美国外科医师学会创伤质量项目2017至2022年数据,共纳入13016例高再出血风险创伤性脑损伤患者,按静脉血栓栓塞预防时机分为12个暴露组。
  • 24小时内(≤24 h)启动化学性静脉血栓栓塞预防与ICU停留延长和通气天数减少的可能性降低相关, regardless of prior anticoagulation use or bleeding disorder。
  • 在>24小时至<72小时窗口内放置下腔静脉滤器与ICU和通气时间延长相关。
  • 24小时内启动化学性静脉血栓栓塞预防未增加死亡率。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于高再出血风险创伤性脑损伤患者,作者认为24小时内启动化学性静脉血栓栓塞预防可显著减少ICU停留和通气天数而不增加死亡率。
  • 下腔静脉滤器与更长ICU停留和通气天数相关,作者认为这可能反映所治疗疾病的严重程度和潜在死亡风险。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: There is little research on venous thromboembolism (VTE) prophylaxis (PPX) timing of the higher rebleeding risk groups based on size and type of traumatic brain injury (TBI) due to exclusion from previous observational studies, which prohibits the facilitation of an evidence-based strategy. We aim to determine the effect of VTE PPX timing on the high rebleeding risk TBI population based on the modified Berne Norwood Criteria.

METHODS: This retrospective cohort study used the American College of Surgeons Trauma Quality Program Participant Use File from 2017 to 2022. The study population consisted of adult patients who received chemical or mechanical PPX with no missing times and had a blunt high rebleeding risk TBI stratified by a comorbid history of anticoagulation or bleeding disorder with excluded polytrauma. There was a total of 12 exposure groups based on VTE PPX timing with the outcomes of interest being intensive care unit (ICU) stay, ventilation days, and mortality.

RESULTS: A total of 13,016 patients were included in the exploratory analysis. Early initiation of chemical VTE PPX (within ≤ 24 h) was associated with a reduced likelihood of prolonged ICU stay and ventilation days, regardless of prior anticoagulation use or bleeding disorder. In contrast, inferior vena cava filter placement within the > 24-h to < 72-h window was associated with increased ICU and ventilation duration.

CONCLUSIONS: This study highlights the benefits of initiating chemical VTE PPX within 24 h for patients wih high rebleeding risk TBI, demonstrating significant reductions in ICU stays and ventilation days without an increase in mortality rates. Additionally, although inferior vena cava filters are associated with longer ICU stays and increased ventilation days, this may reflect the greater severity and potential mortality risk of the conditions being treated.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Rhodes-Lyons HX, Elkbuli A, Kumar S, et al. An Exploratory Analysis of Chemical and Mechanical VTE Prophylaxis in Patients with High Rebleeding Risk Traumatic Brain Injury. Neurocrit Care. 2025. PMID: 40399656. doi:10.1007/s12028-025-02283-4

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。